Salisbury Foundation Trust


Internal Reference Number: FOI_5450

Date Request Received: 20/12/2019 15:12:09

Date Request Replied To: 04/02/2020 10:30:14

This response was sent via: By Email

Request Summary: drugs for non-small cell lung cancer (NSCLC)

Request Category: Private Individuals

Question Number 1:
Within your health trust how many patients are currently [within the past 3 months] being treated with the following regardless of patient diagnosis
Abemaciclib + aromatase inhibitor *
Abemaciclib + Fulvestrant
Alpelisib + Fulvestrant
Everolimus + Exemestane
Fulvestrant as a single agent
Gemcitabine + paclitaxel
Answer To Question 1:
Abemaciclib + aromatase inhibitor 0
Abemaciclib + Fulvestrant 1
Alpelisib + Fulvestrant 0
Atezolizumab 9
Bevacizumab 14
Eribulin 1
Everolimus + Exemestane 1
Fulvestrant as a single agent 8
Gemcitabine + paclitaxel 0
Lapatinib 0
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E:
© 2021 Salisbury NHS Foundation Trust
Trust Values